These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 12945238)

  • 1. [Primary prevention of sudden cardiac death in 2003. Role of implantable automatic defibrillators].
    Mélon P
    Rev Med Liege; 2003 Jun; 58(6):396-9. PubMed ID: 12945238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indications for implantable cardioverter defibrillator (ICD) therapy. Study Group on Guidelines on ICDs of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology.
    Hauer RN; Aliot E; Block M; Capucci A; Lüderitz B; Santini M; Vardas PE;
    Eur Heart J; 2001 Jul; 22(13):1074-81. PubMed ID: 11428848
    [No Abstract]   [Full Text] [Related]  

  • 3. Risks and challenges of implantable cardioverter-defibrillators in young adults.
    Sherrid MV; Daubert JP
    Prog Cardiovasc Dis; 2008; 51(3):237-63. PubMed ID: 19026858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk assessment and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
    Slade AK; Camm AJ
    Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():37-49. PubMed ID: 8734163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective implantation of cardioverter-defibrillators in patients with genetic heart disease and sudden death risk.
    Kamath GS; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():32-40. PubMed ID: 20089485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
    Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
    Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implantable defibrillators in long QT syndrome, Brugada syndrome, hypertrophic cardiomyopathy, and arrhythmogenic right ventricular cardiomyopathy.
    Dohadwala M; Link MS
    Cardiol Clin; 2014 May; 32(2):305-18. PubMed ID: 24793806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short QT syndrome: successful prevention of sudden cardiac death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis.
    Schimpf R; Bauersfeld U; Gaita F; Wolpert C
    Heart Rhythm; 2005 Apr; 2(4):416-7. PubMed ID: 15851347
    [No Abstract]   [Full Text] [Related]  

  • 10. Implantable cardioverter defibrillators in children.
    Chun TU; Collins KK; Dubin AM
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):561-71. PubMed ID: 15225115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [14-year experience with implantable cardioverter/defibrillators: determination of prognosis and discharge behavior].
    Vester EG; Dees H; Dobran I; Hennersdorf M; Perings C; Heydthausen M; Winter J; Strauer BE
    Z Kardiol; 2000; 89 Suppl 3():194-205. PubMed ID: 10810803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of arrhythmias and prevention of sudden death in hypertrophic cardiomyopathy.
    Adabag AS; Maron BJ
    Ann Noninvasive Electrocardiol; 2007 Apr; 12(2):171-80. PubMed ID: 17593187
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillators in children: a single-institutional experience.
    Wilson WR; Greer GE; Grubb BP
    Ann Thorac Surg; 1998 Mar; 65(3):775-8. PubMed ID: 9527212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing.
    Jackson N; Viswanathan K; Cameron D; Nair K
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ
    Cardiol Rev; 2002; 10(3):173-81. PubMed ID: 12047795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter defibrillator criteria for primary and secondary prevention of pediatric sudden cardiac death.
    Berul CI
    Pacing Clin Electrophysiol; 2009 Jul; 32 Suppl 2():S67-70. PubMed ID: 19602167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of implantable pacemakers and implantable defibrillators in hypertrophic cardiomyopathy.
    Freedman RA
    Curr Opin Cardiol; 2001 Jan; 16(1):58-65. PubMed ID: 11124720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical management and prevention of sudden cardiac death.
    Yousuf O; Chrispin J; Tomaselli GF; Berger RD
    Circ Res; 2015 Jun; 116(12):2020-40. PubMed ID: 26044254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The automatic implantable cardioverter-defibrillator: technology for preventing sudden cardiac death.
    Thakor NV; Natarajan A
    Med Des Mater; 1991 Mar; 1(3):16-24. PubMed ID: 10147992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.